By Bryan A. Wolf, MD, PhD, Chief Scientific Officer and Director of the Research Institute
Every space flight mission requires a carefully planned trajectory, and similarly the national Cancer Moonshot initiative needed a scientific roadmap to reach its ambitions of accelerating the prevention, diagnosis, and treatment of cancer to make a decade of progress in the next five years. In September,
An international collaboration of researchers has identified several progressive series of mutations that occur in tumor cells responsible for aggressive subsets of neuroblastoma that relapse after chemotherapy.
A pediatric oncologist with the Cancer Center at The Children’s Hospital of Philadelphia recently received a national award highlighting his lifetime research on neuroblastoma, the most common solid tumor of childhood. The American Society of Clinical Oncology conferred one of its highest awards on Garrett M. Brodeur, MD, who was given the Pediatric Oncology Award and delivered the Pediatric Oncology Lecture.
The Barrett Lab studies the immune function of children with cancer. This research program takes two paths: investigating possible immune deficiencies that result in children developing cancer and developing immune-based therapies for childhood cancer.